Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on February 23, 2006

Stroke. 2006
Published online before print February 23, 2006, doi: 10.1161/01.STR.0000206281.77178.ac
A more recent version of this article appeared on April 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/4/1087    most recent
01.STR.0000206281.77178.acv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yenari, M. A.
Right arrow Articles by Giffard, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yenari, M. A.
Right arrow Articles by Giffard, R. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
*HYDROGEN PEROXIDE
*MINOCYCLINE
Related Collections
Right arrow Animal models of human disease

Submitted on August 9, 2005
Revised on September 29, 2005
Accepted on November 8, 2005

Microglia Potentiate Damage to Blood-Brain Barrier Constituents. Improvement by Minocycline In Vivo and In Vitro

Midori A. Yenari MD*; Lijun Xu MD; Xian Nan Tang MD; Yanli Qiao MD; and Rona G. Giffard MD, PhD

From the Departments of Anesthesia (L.X., X.N.T., Y.Q., R.G.G.) and Neurosurgery (R.G.G.), Stanford University School of Medicine, California; and Department of Neurology (M.A.Y., X.N.T.), University of California, San Francisco, and the San Francisco Veterans Affairs Medical Center, California.

* To whom correspondence should be addressed. E-mail: yenari{at}alum.mit.edu.

Background--Blood-brain barrier (BBB) disruption after stroke can worsen ischemic injury by increasing edema and causing hemorrhage. We determined the effect of microglia on the BBB and its primary constituents, endothelial cells (ECs) and astrocytes, after ischemia using in vivo and in vitro models.

Methods and Results--Primary astrocytes, ECs, or cocultures were prepared with or without added microglia. Primary ECs were more resistant to oxygen-glucose deprivation/reperfusion than astrocytes. ECs plus astrocytes showed intermediate vulnerability. Microglia added to cocultures nearly doubled cell death. This increase was prevented by minocycline and apocynin. In vivo, minocycline reduced infarct volume and neurological deficits and markedly reduced BBB disruption and hemorrhage in mice after experimental stroke.

Conclusions--Inhibition of microglial activation may protect the brain after ischemic stroke by improving BBB viability and integrity. Microglial inhibitors may prove to be an important treatment adjunct to fibrinolysis.


Key words: blood-brain barrier • inflammation • ischemia • microglia




This article has been cited by other articles:


Home page
J. Neurosci.Home page
G. S. Kim, J. E. Jung, K. Niizuma, and P. H. Chan
CK2 Is a Novel Negative Regulator of NADPH Oxidase and a Neuroprotectant in Mice after Cerebral Ischemia
J. Neurosci., November 25, 2009; 29(47): 14779 - 14789.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Drabek, S. A. Tisherman, L. Beuke, J. Stezoski, K. Janesko-Feldman, M. Lahoud-Rahme, and P. M. Kochanek
Deep Hypothermia Attenuates Microglial Proliferation Independent of Neuronal Death After Prolonged Cardiac Arrest in Rats
Anesth. Analg., September 1, 2009; 109(3): 914 - 923.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. S. Machado, I. Y. Sazonova, A. Kozak, D. C. Wiley, A. B. El-Remessy, A. Ergul, D. C. Hess, J. L. Waller, and S. C. Fagan
Minocycline and Tissue-Type Plasminogen Activator for Stroke: Assessment of Interaction Potential
Stroke, September 1, 2009; 40(9): 3028 - 3033.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
X. N. Tang, Q. Wang, M. A. Koike, D. Cheng, M. L. Goris, F. G. Blankenberg, and M. A. Yenari
Monitoring the Protective Effects of Minocycline Treatment with Radiolabeled Annexin V in an Experimental Model of Focal Cerebral Ischemia
J. Nucl. Med., November 1, 2007; 48(11): 1822 - 1828.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Paul, S. Strickland, and J. P. Melchor
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease
J. Exp. Med., August 6, 2007; 204(8): 1999 - 2008.
[Abstract] [Full Text] [PDF]